LMB763 NCT02913105


Laboratory : NOVARTIS

Study Name : 

Phase 2

Study Number : NCT02913105

Number of patients recruited : 100

Probability to be under placebo : 50%

Contacts : 

Contact: Novartis Pharmaceuticals

1-888-669-6682

Contact: Novartis Pharmaceuticals

+41 613241111






Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016